SOUTH SAN FRANCISCO, Calif., Sept. 13 /PRNewswire-FirstCall/ -- Anesiva, ( Nachrichten ) Inc. today announced that it has initiated a new Phase 2 study of Adlea(TM) (formerly 4975) for the relief of post-operative pain in patients undergoing total knee replacement surgery, also called total knee arthroplasty (TKA). Adlea is a long-acting, non-opiate analgesic drug designed to provide pain relief ...
From: www.finanznachrichten.de
Thursday, September 13, 2007
TM) for Pain Relief Following Knee Replacement Surgery
Subscribe to:
Post Comments (Atom)
![Digitalpoint Geo Tracking [Enabled]](http://geo.digitalpoint.com/a.png)
![PingOmatic AutoDiscovery [Enabled]](http://www.genuineblogger.com/images/chicklet-pingomatic.gif)
![Made with Palestinian Efforts [True]](http://www.genuineblogger.com/images/yapalestinets.gif)
No comments:
Post a Comment